TITLE

Review: In stable obstructive CAD, PCI plus medical therapy (MT) does not differ from MT alone

AUTHOR(S)
Hudson, Michael P.
PUB. DATE
April 2014
SOURCE
Annals of Internal Medicine;4/15/2014, Vol. 160 Issue 8, pJC8
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article focuses on a study which compares the effectiveness of percutaneous coronary intervention (PCI) plus medical therapy (MT) with only MT in patients with stable obstructive coronary artery disease (CAD) and myocardial ischemia. The study used data from the bibliographical database MEDLINE for randomized controlled trial. The study concluded that there is no difference in both the treatment methods in terms of mortality and cardiovascular events.
ACCESSION #
95572335

 

Related Articles

  • Antiplatelet Therapy to Prevent Cardiovascular Events and Mortality in Patients With Intermittent Claudication. Peng Foo Wong; Lee-Yee Chong; Gerard Stansby // JAMA: Journal of the American Medical Association;3/6/2013, Vol. 309 Issue 9, p926 

    The article presents review of a research that was conducted to investigate whether antiplatelet therapies reduce risk of all-cause mortality, cardiovascular disease (CVD) mortality and cardiovascular events in patients with intermittent suffering with claudication. It further tries to examine...

  • Review: Digoxin does not affect all-cause mortality but reduces hospital admissions. Kumar, P. Dileep // ACP Journal Club;12/15/2015, Vol. 163 Issue 12, p1 

    Question: What are the efficacy and safety of digoxin? Review scope: Included English-language studies compared digoxin with placebo or no treatment in any population. Primary outcome was all-cause mortality. Secondary outcomes included cardiovascular mortality and hospital admission. Review...

  • 'Intensive' programmes improve CVD risk.  // Pulse;9/12/2012, Vol. 72 Issue 29, p13 

    The article focuses on a study by researchers, which found that cardio-vascular mortality could be reduced by up to a fifth by intensive lifestyle interventions in high-risk patients.

  • Decline in cardiovascular mortality in North Karelia and other parts of Finland. Tuomilehto, Jaako; Geboers, Jef; Salonen, Jukka T.; Nissinen, Aulikki; Kuuslasmaa, Kari; Puska, Pekka // British Medical Journal (Clinical Research Edition);10/25/1986, Vol. 293 Issue 6554, p1068 

    Analyzes the decrease of cardiovascular mortality in Finland. Calculations on the linear trends of mortality based on age population and changes of mortality rate; Identification of average percentage of cardiovascular diseases between men and women; Appreciation on the decrease of mortality...

  • Role of Troponin in Patients With Chronic Kidney Disease and Suspected Acute Coronary Syndrome. Stacy, Sylvie R.; Suarez-Cuervo, Catalina; Berger, Zackary; Wilson, Lisa M.; Hsin-Chieh Yeh; Bass, Eric B.; Michos, Erin D. // Annals of Internal Medicine;10/7/2014, Vol. 161 Issue 7, p502 

    Background: Patients with chronic kidney disease (CKD) have high prevalence of elevated serum troponin levels, which makes diagnosis of acute coronary syndrome (ACS) challenging. Purpose: To evaluate the utility of troponin in ACS diagnosis, treatment, and prognosis among patients with CKD. Data...

  • Statins in patients with CKD prove beneficial in reducing cardiovascular events and mortality but show no benefit in patients on dialysis. Krishnan, Sandeep; Jacobson, Terry A. // Evidence Based Medicine;Oct2013, Vol. 18 Issue 5, p175 

    The article presents a study on the benefit of statins in patients with chronic kidney disease (CKD), which appeared in a 2012 issue of the journal "Annals of Internal Medicine." The study employed randomized controlled trial which compared the effects of statin with no treatment control in...

  • Review: CABG reduces long-term mortality and morbidity more than PCI in multivessel coronary disease. Harskamp, Ralf E.; Newby, L. Kristin // Annals of Internal Medicine;4/15/2014, Vol. 160 Issue 8, pJC9 

    The article focuses on a study which compares the effectiveness of coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) in patients with multivessel coronary disease for long-term mortality and morbidity. The study employed data from bibliographical databases such...

  • Independent Prognostic Value of Single and Multiple Non-Specific 12-Lead Electrocardiographic Findings for Long-Term Cardiovascular Outcomes: A Prospective Cohort Study. Sawano, Mitsuaki; Kohsaka, Shun; Okamura, Tomonori; Inohara, Taku; Sugiyama, Daisuke; Shiraishi, Yasuyuki; Watanabe, Makoto; Nakamura, Yasuyuki; Higashiyama, Aya; Kadota, Aya; Okuda, Nagako; Murakami, Yoshitaka; Ohkubo, Takayoshi; Fujiyoshi, Akira; Miura, Katsuyuki; Okayama, Akira; Ueshima, Hirotsugu; null, null // PLoS ONE;6/30/2016, Vol. 11 Issue 6, p1 

    Aims: The long-term prognostic effect of non-specific 12-lead electrocardiogram findings is unknown. We aimed to evaluate the cumulative prognostic impact of axial, structural, and repolarization categorical abnormalities on cardiovascular death, independent from traditional risk scoring...

  • Cardiovascular and other competing causes of death among patients with cancer from 2006 to 2015: An Australian population-based study. Ye, Yuanzi; Otahal, Petr; Marwick, Thomas H.; Wills, Karen E.; Neil, Amanda L.; Venn, Alison J. // Cancer (0008543X);Feb2019, Vol. 125 Issue 3, p442 

    Background: With improved cancer survivorship, cardiovascular disease (CVD) and other noncancer events compete with cancer as the underlying cause of death, but the risks of mortality in competing-risk settings have not been well characterized.Methods: The authors...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics